NT Nykode Therapeutics ASA Stock: price and directors' dealings · Norway · Oslo BørsFollow the Nykode Therapeutics ASA stock price and the full insider trade history of the company, a listed equity based in Norway. Shares trade on the NO market, under the oversight of Oslo Børs. Operating in the Health Care sector, Nykode Therapeutics ASA has recorded 55 public disclosures. The latest transaction was disclosed on 31 August 2026 (Other). Among the most active insiders: Michael Engsig. Every trade is free.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
All Executives55 Thresholds0 Prospectus0 Other0
Declarations 55 total
● Executives
Executives · 31 Aug 2026 (filed)
● Executives
Executives · 27 Aug 2026 (filed)
◇ Executives · 6 Aug 2026 (filed)
◇ Unknown insider (NYKD)
Executives · 20 Jan 2026
600,000 shares @ NOK 7.1792 0.6% of flow Option XOSLOSLO:664566 ● Executives · 24 Nov 2025 (filed)
46,356 shares @ NOK 2.16 21.2% of flow Share XOSLOSLO:660428 ◇ Executives
Executives · 10 Oct 2025 (filed)
● Executives · 10 Oct 2025 (filed)
280,000 shares @ NOK 1.8113 100.0% of flow Share XOSLOSLO:657002 ● Executives · 10 Oct 2025 (filed)
55,944 shares @ NOK 1.79 21.5% of flow Share XOSLOSLO:656985 ◇ Executives
Executives · 9 Jul 2025 (filed)
● Executives · 27 Mar 2025 (filed)
3,000,000 shares @ NOK 2.1388 40.2% of flow Share XOSLOSLO:642414 ● Executives · 20 Dec 2024 (filed)
100,000 shares @ NOK 3.00 1.8% of flow Share XOSLOSLO:635453 ● Executives · 8 Nov 2024 (filed)
5,000,000 shares @ NOK 1.9172 58.0% of flow Share XOSLOSLO:631746 ● Executives · 21 Aug 2024 (filed)
50,000 shares @ NOK 5.65 14.0% of flow Share XOSLOSLO:625848 ◇ Executives
Executives · 1 Jul 2024 (filed)
◇ Unknown insider (NYKD)
Executives · 15 May 2024
65,000 shares @ NOK 16.2267 0.2% of flow Option XOSLOSLO:619739 ● Executives · 26 Mar 2024 (filed)
25,000 shares @ NOK 14.97 49.8% of flow Share XOSLOSLO:614682 ● Executives · 21 Mar 2024 (filed)
20,311 shares @ NOK 15.276 100.0% of flow Share XOSLOSLO:614248 ● Executives · 13 Mar 2024 (filed)
10,000 shares @ NOK 14.00 29.5% of flow Share XOSLOSLO:613304 ● Executives · 8 Mar 2024 (filed)
25,000 shares @ NOK 14.81 50.2% of flow Share XOSLOSLO:613028 ● Executives · 8 Mar 2024 (filed)
40,000 shares @ NOK 13.81 28.1% of flow Share XOSLOSLO:612998 ● Executives · 4 Mar 2024 (filed)
20,000 shares @ NOK 16.59 70.5% of flow Share XOSLOSLO:612556 ● Executives · 29 Feb 2024 (filed)
6,000 shares @ NOK 16.71 21.8% of flow Share XOSLOSLO:612321 ● Executives · 24 Nov 2023 (filed)
@ €0.7486 Option XOSLOSLO:604960 ● Executives · 31 Oct 2023 (filed)
9,850 shares @ NOK 17.10 35.5% of flow Share XOSLOSLO:602645 ● Executives · 27 Oct 2023 (filed)
20,000 shares @ NOK 16.36 16.1% of flow Share XOSLOSLO:602442 25 of 55 declarations
Load more (30 remaining) 关于 Nykode Therapeutics ASA Nykode Therapeutics ASA 是一家生物制药公司,专注于开发用于治疗癌症和传染病的免疫疗法。该公司在 XOSL 市场上市。